Cannabis Bioscience International Holdings, Inc. (CBIH) Notes Payables (2023 - 2026)

Cannabis Bioscience International Holdings has disclosed Notes Payables across 4 years of filings, most recently posting $111721.0 for Q1 2026.

• In Q1 2026, Notes Payables fell 10.44% year-over-year to $111721.0; the TTM figure through Feb 2026 stood at $111721.0 (down 10.44% YoY), while the FY2025 annual figure was $111722.0, down 17.97% from the prior year.
• Notes Payables came in at $111721.0 for Q1 2026 at Cannabis Bioscience International Holdings, roughly flat from $111721.0 in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $151267.0 in Q4 2023 to a low of $111721.0 in Q3 2025.
• Average Notes Payables over 4 years is $123365.2, with a median of $112629.0 recorded in 2024.
• The largest YoY upside for Notes Payables was 12.18% in 2024 against a maximum downside of 25.54% in 2024.
• Over 4 years, Notes Payables stood at $151267.0 in 2023, then slipped by 25.54% to $112629.0 in 2024, then slipped by 0.81% to $111721.0 in 2025, then changed by 0.0% to $111721.0 in 2026.
• Per Business Quant data, the three most recent Notes Payables figures were $111721.0 in Q1 2026, $111721.0 in Q4 2025, and $111721.0 in Q3 2025.